EP Patent

EP0309477B1 — Ecteinascidins 729, 743, 745, 759a, 759b and 770

Assigned to University of Illinois at Urbana Champaign · Expires 1991-11-06 · 35y expired

What this patent protects

Novel compounds ecteinascidins 729, 743, 745, 759A, 759B, and 770 having antibacterial and antitumor properties.

USPTO Abstract

Novel compounds ecteinascidins 729, 743, 745, 759A, 759B, and 770 having antibacterial and antitumor properties.

Drugs covered by this patent

Patent Metadata

Patent number
EP0309477B1
Jurisdiction
EP
Classification
—
Expires
1991-11-06
Drug substance claim
No
Drug product claim
No
Assignee
University of Illinois at Urbana Champaign
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.